Sonoma Pharmaceuticals Inc (SNOA)

$1.21 0.00 (N/A)
Market Cap 5.79M
Revenue (ttm) 19.53M
Net Income (ttm) -3.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -16.28%
Debt to Equity Ratio 0.00
Volume 60,600
Avg Vol 277,514
Day's Range N/A - N/A
Shares Out 4.79M
Stochastic %K 65%
Beta 1.27
Analysts Strong Sell
Price Target $14.80

Company Profile

Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild t...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 800 759 9305
Address:
5445 Conestoga Court, Suite 150, Boulder, United States
AXLFI_HQ
AXLFI_HQ Jul. 2 at 10:30 PM
$SNOA FDA regulatory approvals are expanding for healthcare innovations including novel antibiotics, immunotherapies, and precision diagnostics, creating new market opportunities and growth drivers for medical device and pharmaceutical companies. Learn more: https://axlfi.com/themes/357
0 · Reply
BioTuesdays
BioTuesdays Jun. 30 at 7:23 PM
$SNOA has received a new 510(k) clearance from the FDA for its Microdacyn Wound Irrigation Solution, including expanded claims, clearance for multiple use, and additional packaging configurations. https://biotuesdays.com/2026/06/30/fda-grants-sonoma-510k-clearance-for-microdacyn-wound-irrigation-solution/
0 · Reply
STACKD0E
STACKD0E Jun. 30 at 1:25 PM
$VELO $SNOA $JAGX ✨️
0 · Reply
vmkhc
vmkhc Jun. 30 at 1:07 PM
$SNOA FDA pr finally out
0 · Reply
25Trump
25Trump Jun. 30 at 1:03 PM
$SNOA
0 · Reply
Stock_Catcher
Stock_Catcher Jun. 30 at 1:01 PM
$SNOA Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution
0 · Reply
kurseskeezy
kurseskeezy Jun. 29 at 9:06 PM
$SNOA $CALC
1 · Reply
kurseskeezy
kurseskeezy Jun. 29 at 3:47 PM
$CALC $SNOA FDA 510K approval today, no PR 👀
3 · Reply
vmkhc
vmkhc Jun. 29 at 12:35 PM
$SNOA 510k on #Fda website. 140k vol vs 30k Friday https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K261023
0 · Reply
d_risk
d_risk Jun. 23 at 11:59 AM
$SNOA - Sonoma Pharmaceuticals, Inc. - 10K - Updated Risk Factors SNOA drops explicit going-concern and chronic-loss language while highlighting reliance on third‑party distributors and flags a new Nasdaq proposal that could trigger faster suspension/delisting if its market value of listed securities falls below $5M. #Pharmaceuticals #GoingConcern #ThirdPartyDistribution #NasdaqListingRisk #MarketValue 🟢 Added 🟠 Removed https://d-risk.ai/SNOA/10-K/2026-06-16
0 · Reply
Latest News on SNOA
Sonoma Pharmaceuticals receives 510(k) clearance for Microdacyn solution

2026-06-30T13:05:15.000Z - 4 days ago

Sonoma Pharmaceuticals receives 510(k) clearance for Microdacyn solution

Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution

Jun 30, 2026, 9:00 AM EDT - 4 days ago

Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results

Jun 16, 2026, 4:15 PM EDT - 18 days ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results

Sonoma Pharmaceuticals prices 2.96M shares at $1.35 in public offering

2026-04-24T13:32:34.000Z - 2 months ago

Sonoma Pharmaceuticals prices 2.96M shares at $1.35 in public offering

Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering

Apr 24, 2026, 9:21 AM EDT - 2 months ago

Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering

Sonoma Pharmaceuticals files to sell units, no amount given

2026-04-17T21:31:03.000Z - 2 months ago

Sonoma Pharmaceuticals files to sell units, no amount given

Sonoma announces U.S. retail launch of advanced burn relief hydrogel

2026-03-24T12:45:50.000Z - 3 months ago

Sonoma announces U.S. retail launch of advanced burn relief hydrogel

CVS WMT

Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart

Mar 24, 2026, 8:30 AM EDT - 3 months ago

Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart

Sonoma Pharmaceuticals launches Aquanil AD

2026-03-18T13:00:52.000Z - 3 months ago

Sonoma Pharmaceuticals launches Aquanil AD

Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin

Mar 18, 2026, 8:30 AM EDT - 3 months ago

Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results

Feb 10, 2026, 4:10 PM EST - 5 months ago

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results

Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development

Jan 28, 2026, 4:15 PM EST - 5 months ago

Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development

RNA

Sonoma Pharmaceuticals’ Reliefacyn Advanced receives NRS Seal of Acceptance

2025-11-13T13:50:15.000Z - 8 months ago

Sonoma Pharmaceuticals’ Reliefacyn Advanced receives NRS Seal of Acceptance

National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

Nov 13, 2025, 8:30 AM EST - 8 months ago

National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf

Nov 6, 2025, 4:01 PM EST - 8 months ago

Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf

Sonoma Pharmaceuticals reports Q2 EPS (32c) vs. (59c) last year

2025-11-04T14:00:39.000Z - 8 months ago

Sonoma Pharmaceuticals reports Q2 EPS (32c) vs. (59c) last year

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results

Nov 4, 2025, 8:56 AM EST - 8 months ago

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results

Sonoma Pharmaceuticals, Medline launch HOCI wound cleanser

2025-10-14T12:40:28.000Z - 9 months ago

Sonoma Pharmaceuticals, Medline launch HOCI wound cleanser

Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals

Oct 14, 2025, 8:30 AM EDT - 9 months ago

Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals

Sonoma Pharmaceuticals lists facial spray under FDA’s MoCRA

2025-10-07T13:30:41.000Z - 9 months ago

Sonoma Pharmaceuticals lists facial spray under FDA’s MoCRA

Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA

Oct 7, 2025, 8:30 AM EDT - 9 months ago

Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA

Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

Sep 25, 2025, 4:01 PM EDT - 10 months ago

Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced

Aug 26, 2025, 8:30 AM EDT - 11 months ago

National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced

Why Is Sonoma Pharmaceuticals Stock (SNOA) Up 105% Today?

2025-08-15T00:51:00.000Z - 11 months ago

Why Is Sonoma Pharmaceuticals Stock (SNOA) Up 105% Today?

AMZN WMT

Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains

Aug 13, 2025, 4:01 PM EDT - 11 months ago

Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results

Aug 7, 2025, 4:15 PM EDT - 11 months ago

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results

Jun 17, 2025, 4:10 PM EDT - 1 year ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results

Sonoma Pharmaceuticals registers acne products in the United Kingdom

2025-04-22T20:15:23.000Z - 1 year ago

Sonoma Pharmaceuticals registers acne products in the United Kingdom

Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain

Apr 22, 2025, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain

Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)

Mar 10, 2025, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)

Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando

Feb 25, 2025, 4:01 PM EST - 1 year ago

Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results

Feb 5, 2025, 4:05 PM EST - 1 year ago

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results

Sonoma transitions first products to new EU MDR requirements

2024-12-05T13:50:39.000Z - 1 year ago

Sonoma transitions first products to new EU MDR requirements

Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices

Dec 5, 2024, 8:30 AM EST - 1 year ago

Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices

Sonoma Pharmaceuticals announces relaunch of dermatology, eye care lines

2024-11-21T21:20:46.000Z - 1 year ago

Sonoma Pharmaceuticals announces relaunch of dermatology, eye care lines

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States

Nov 21, 2024, 4:06 PM EST - 1 year ago

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel

Nov 11, 2024, 4:20 PM EST - 1 year ago

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel

FDA grants Sonoma 510(k) approval for Microdacyn Hydrogel

2024-11-11T14:55:45.000Z - 1 year ago

FDA grants Sonoma 510(k) approval for Microdacyn Hydrogel

Sonoma Pharmaceuticals reports Q2 (59c) vs ($5.75) last year

2024-11-07T13:55:41.000Z - 1 year ago

Sonoma Pharmaceuticals reports Q2 (59c) vs ($5.75) last year

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results

Nov 7, 2024, 8:45 AM EST - 1 year ago

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results

Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf

Oct 31, 2024, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf

Sonoma Pharmaceuticals expands partnership with healthcare distributor

2024-10-22T12:45:45.000Z - 1 year ago

Sonoma Pharmaceuticals expands partnership with healthcare distributor

Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada

Oct 22, 2024, 8:35 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada

Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences

Oct 21, 2024, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences

Sonoma Pharmaceuticals regains compliance with Nasdaq requirement

2024-09-19T12:45:24.000Z - 1 year ago

Sonoma Pharmaceuticals regains compliance with Nasdaq requirement

Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

Sep 19, 2024, 8:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution

Sep 17, 2024, 8:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution

Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line

Sep 11, 2024, 8:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line

Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock

Aug 28, 2024, 6:10 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff

Aug 26, 2024, 8:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff

Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States

Aug 21, 2024, 8:45 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results

Aug 8, 2024, 4:10 PM EDT - 2 years ago

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results

Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine

Jul 9, 2024, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results

Jun 17, 2024, 5:00 PM EDT - 2 years ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results

Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores

May 9, 2024, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores

Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States

Apr 9, 2024, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States

Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections

Apr 4, 2024, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections

Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences

Mar 28, 2024, 4:01 PM EDT - 2 years ago

Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences

Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals

Mar 27, 2024, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results

Feb 8, 2024, 4:10 PM EST - 2 years ago

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results

Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use

Jan 23, 2024, 7:30 AM EST - 2 years ago

Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network

Jan 9, 2024, 9:15 AM EST - 2 years ago

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results

Nov 13, 2023, 4:10 PM EST - 2 years ago

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results

Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference

Nov 3, 2023, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference

Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock

Oct 26, 2023, 9:10 AM EDT - 2 years ago

Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock

National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

Aug 15, 2023, 7:30 AM EDT - 3 years ago

National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial Results

Aug 10, 2023, 4:15 PM EDT - 3 years ago

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial Results

AXLFI_HQ
AXLFI_HQ Jul. 2 at 10:30 PM
$SNOA FDA regulatory approvals are expanding for healthcare innovations including novel antibiotics, immunotherapies, and precision diagnostics, creating new market opportunities and growth drivers for medical device and pharmaceutical companies. Learn more: https://axlfi.com/themes/357
0 · Reply
BioTuesdays
BioTuesdays Jun. 30 at 7:23 PM
$SNOA has received a new 510(k) clearance from the FDA for its Microdacyn Wound Irrigation Solution, including expanded claims, clearance for multiple use, and additional packaging configurations. https://biotuesdays.com/2026/06/30/fda-grants-sonoma-510k-clearance-for-microdacyn-wound-irrigation-solution/
0 · Reply
STACKD0E
STACKD0E Jun. 30 at 1:25 PM
$VELO $SNOA $JAGX ✨️
0 · Reply
vmkhc
vmkhc Jun. 30 at 1:07 PM
$SNOA FDA pr finally out
0 · Reply
25Trump
25Trump Jun. 30 at 1:03 PM
$SNOA
0 · Reply
Stock_Catcher
Stock_Catcher Jun. 30 at 1:01 PM
$SNOA Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution
0 · Reply
kurseskeezy
kurseskeezy Jun. 29 at 9:06 PM
$SNOA $CALC
1 · Reply
kurseskeezy
kurseskeezy Jun. 29 at 3:47 PM
$CALC $SNOA FDA 510K approval today, no PR 👀
3 · Reply
vmkhc
vmkhc Jun. 29 at 12:35 PM
$SNOA 510k on #Fda website. 140k vol vs 30k Friday https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K261023
0 · Reply
d_risk
d_risk Jun. 23 at 11:59 AM
$SNOA - Sonoma Pharmaceuticals, Inc. - 10K - Updated Risk Factors SNOA drops explicit going-concern and chronic-loss language while highlighting reliance on third‑party distributors and flags a new Nasdaq proposal that could trigger faster suspension/delisting if its market value of listed securities falls below $5M. #Pharmaceuticals #GoingConcern #ThirdPartyDistribution #NasdaqListingRisk #MarketValue 🟢 Added 🟠 Removed https://d-risk.ai/SNOA/10-K/2026-06-16
0 · Reply
focafoca99
focafoca99 Jun. 18 at 9:07 PM
$SNOA now has more room under its at-the-market program after lifting the offering capacity to $3.64M.
1 · Reply
BigBoyTroy
BigBoyTroy Jun. 17 at 12:38 PM
$HYPD $ORKT $SNOA swinging these come join free discord the link is in my stoctwits Profile/website my bullish peeps
0 · Reply
JLCw
JLCw Jun. 17 at 3:01 AM
Final Watchlist 06/17 $COSM $GDHG $PAVS $SNOA $KMRK Saw meaningful volume expansion and have fresh stories behind them. Looking for continuation if momentum rotates beyond these names JL
0 · Reply
BigCat23
BigCat23 Jun. 16 at 10:30 PM
$SNOA looks likes she wants to breakout
0 · Reply
JCH007
JCH007 Jun. 16 at 9:56 PM
$SNOA No volume. What a shame. I'm out. GLTA who are holding.
0 · Reply
Alpha__Trading
Alpha__Trading Jun. 16 at 9:29 PM
$SNOA hasn't touched 200DMA for half a year.....
0 · Reply
JCH007
JCH007 Jun. 16 at 9:05 PM
$SNOA Going to take a stab at it. Earnings report was good: - Revenue up 48% year-over-year - Net loss improved 25% - EBITDA loss improved 66%. - Growth driven by actual U.S. sales, not some vague future projection. - Revenue increased in multiple regions.
0 · Reply
BigCat23
BigCat23 Jun. 16 at 8:42 PM
$SNOA going to wake up here
0 · Reply
Alpha__Trading
Alpha__Trading Jun. 16 at 8:33 PM
$SNOA they closed offering silently, going to bid
0 · Reply
biotrade123
biotrade123 Jun. 2 at 4:04 PM
$SNOA dead board?
0 · Reply
Ankerbanker
Ankerbanker May. 28 at 8:26 PM
$SNOA 👀
0 · Reply
StockfatherOG
StockfatherOG May. 21 at 1:10 PM
$SNOA bottomed biotech gem. One day we will take up and it’s up 200% Highly shorted too. The squeeze will be glorious. Chart has massive room to go parabolic.
0 · Reply